About Calantic™ Digital Solutions
Calantic™ Digital Solutions is a suite of digital radiology AI-enabled applications which assist radiologists and their teams at critical steps within a patient’s treatment journey. The vendor-neutral, cloud-based platform includes a growing number of applications designed to aid in prioritization, lesion detection, and quantification, as well as apps that automate routine tasks and measurements, improve the radiology suites’ workflow, and potentially free up time for radiologists and their teams. The offering is orchestrated by body region and diagnostic procedure, initially focusing on thoracic and neurological diseases, such as pulmonary nodule detection and triage of suspected intracerebral hemorrhage and large vessel occlusions. More disease-specific application packages will be added moving forward. Bayer provides services around installation, configuration, and training of the platform and its applications. First launch markets to include the US and several European countries, with more regions to follow, upon local regulatory approvals as applicable.
Ad Statistics
Times Displayed: 63870
Times Visited: 2092 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About AI in Medical Imaging
The radiology AI market is growing dynamically, with an estimated compound annual growth rate (CAGR) of more than 25 percent through 2025.1 Innovation powered by AI is more needed than ever: aging populations and changing lifestyles are leading to an increase in chronic conditions such as cardiovascular disease and cancer.5,6 Consequently, the demand for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing.
About Radiology at Bayer
Everyone deserves clear answers about their health, starting with an early and accurate diagnosis. As a true life-science company with a heritage of over 100 years in radiology, Bayer is committed to providing excellence, from innovative products to high-quality services. Bayer’s portfolio of contrast media for computed tomography (CT), X-Ray and magnetic resonance imaging (MRI), devices for their precise administration, informatics solutions to support efficient and optimized patient care, as well as acknowledged educational programs, generated €1.8bn sales in 2021. Following the company’s ambition to outperform the radiology market’s average annual growth of five percent until 2030, Bayer is strongly committed to research and development, including leveraging AI and driving innovation in medical imaging. Each of these offerings provide effective tools to support radiologists in their mission to deliver treatment critical answers and clear direction – from diagnosis to care.
